Medicare Enrolled

Dr. Hugh Windom, M.D.

Allergy Physician · Sarasota, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3570 S TUTTLE AVE, Sarasota, FL 34239
9419274888
In practice since 2005 (20 years)
NPI: 1013902204 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Windom from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Windom? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Windom

Dr. Hugh Windom is an allergy physician in Sarasota, FL, with 20 years in practice. Based on federal Medicare data, Dr. Windom performed 11,005 Medicare services across 1,343 unique beneficiaries.

Between the years covered by Open Payments, Dr. Windom received a total of $34,936 from 41 pharmaceutical and/or device companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Windom is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 26% volume in FL$ $34,936 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,005
Medicare services
Top 26% in FL for allergy physician
1,343
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~550 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Omalizumab injection (Xolair) for asthma/allergy3,210$30$40
Allergy skin test3,097$3$4
Test for allergy using allergenic extract injected into skin1,198$6$8
Allergy immunotherapy preparation900$11$14
Office visit, established patient (30-39 min)677$80$115
Test for allergy using combination of methods with drug or biological417$15$21
Allergy injection therapy, multiple injections369$7$12
Professional service for single injection of allergen366$6$9
Office visit, established patient (20-29 min)215$55$76
New patient office visit (45-59 min)196$114$167
Drug injection, under skin or into muscle125$11$14
Injection for rapid desensitization to allergen56$104$141
Test to measure expiratory airflow and volume changes before and after medication administration50$25$59
Test for allergy using ingested items, initial 2 hours46$84$120
New patient office visit, complex (60-74 min)43$142$211
Flu vaccine, high-dose20$34$35
Flu vaccine administration20$29$30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$34,936
Total received (2018-2024)
Avg $4,991/year across 7 years
Top 9% in FL for allergy physician
41
Companies
930
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,366 (72.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,027 (23.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,544 (4.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,316
2023
$8,122
2022
$11,641
2021
$2,082
2020
$3,107
2019
$3,491
2018
$3,177

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Aimmune Therapeutics, Inc.
$8,010
Chiesi USA, Inc.
$4,290
AstraZeneca Pharmaceuticals LP
$2,191
GlaxoSmithKline, LLC.
$1,990
Octapharma USA, Inc.
$1,947
GENZYME CORPORATION
$1,854
ALK-Abello, Inc
$1,822
Novartis Pharmaceuticals Corporation
$1,741
Mylan Specialty L.P.
$1,647
CSL Behring
$1,630
Takeda Pharmaceuticals U.S.A., Inc.
$1,111
Regeneron Healthcare Solutions, Inc.
$1,082
Shire North American Group Inc
$645
Genentech USA, Inc.
$620
kaleo, Inc.
$603
Pharming Healthcare, Inc.
$365
PFIZER INC.
$360
Grifols USA, LLC
$356
Kaleo, Inc.
$315
BioCryst US Sales Co., LLC
$265
ADMA BioManufacturing LLC
$259
AbbVie Inc.
$254
Optinose US, Inc.
$233
Teva Pharmaceuticals USA, Inc.
$228
Amgen Inc.
$204
ABBVIE INC.
$185
OptiNose US, Inc.
$151
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
Phadia US Inc.
$80
Incyte Corporation
$55
Sunovion Pharmaceuticals Inc.
$55
LEO Pharma Inc.
$53
Horizon Therapeutics plc
$49
Merck Sharp & Dohme LLC
$38
Hikma Pharmaceuticals USA
$36
Circassia Inc.
$24
BioCryst Pharmaceuticals, Inc.
$23
Covis Pharma GmBH
$23
Horizon Pharma plc
$18
Merck Sharp & Dohme Corporation
$17
AIMMUNE THERAPEUTICS, INC.
$13
Top 3 companies account for 41.5% of total payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · ALVESCO · ANORO ELLIPTA · AUVI-Q · AirDuo Digihaler · ArmonAir Digihaler · Auvi-Q · BREO · BREZTRI · BROVANA · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dust mite (D. farinae) · Dymista · EOHILIA · EUCRISA · FARXIGA · FASENRA · FIRAZYR · Gamunex-C · Grastek · HYQVIA · Haegarda · Hizentra · ImmunoCAP · NIOX · NUCALA · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · PAZEO · Privigen · ProAir Digihaler · Prolastin-C Liquid · QVAR · RINVOQ · RUCONEST · Ryaltris · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · Utibron · XOLAIR · Xembify · Xhance · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for allergy physician in FL.

Equivalent to $317 per 100 Medicare services performed
Looking for a allergy physician in Sarasota?
Compare allergy physicians in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse allergy physicians nearby

Geographic Context

Allergy Physicians within 10 mi
8
Per 100K population
1.8
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Windom is a mixed practice specialist, with above-average Medicare volume (top 26% in FL), and high industry engagement (low-engagement, top 9%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Windom experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Windom performed 3,210 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Windom receive payments from pharmaceutical companies?
Yes. Dr. Windom received a total of $34,936 from 41 companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Windom's costs compare to other allergy physicians in Sarasota?
Dr. Windom's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Windom) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →